Coral Laboratories [CORALAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Coral Laboratories Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Coral Laboratories Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 11.06 67.11 Coral Laboratories Ltd.
Price-to-Book Ratio 0.73 10.82 Coral Laboratories Ltd.
Debt-to-Equity Ratio 0.41 0.58 Coral Laboratories Ltd.
PEG Ratio -0.20 4.63 Divi's Laboratories Ltd.
EV/EBITDA 4.44 48.63 Coral Laboratories Ltd.
Profit Margin (TTM) 15.97% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 5.58% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 5.58% 29.65% Divi's Laboratories Ltd.
Return on Equity 12.01% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 10.53% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-41.67M $2.15B Divi's Laboratories Ltd.
Dividend Yield 0.29% 0.91% Divi's Laboratories Ltd.
1-Year Return -18.38% -0.43% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.77 16.18 Coral Laboratories Ltd.
Enterprise Value $532.28M $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 0.61 15.86 Coral Laboratories Ltd.
Gross Profit Margin (TTM) 59.74% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $245 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $39.14 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.90 0.19 Divi's Laboratories Ltd.

Coral Laboratories Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

CORALAB
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories Ltd.2.22%0.75%9.98%18.09%9.54%13.35%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories Ltd.-18.38%101.77%4.69%9.89%526.74%564.59%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Coral Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricCORALABDIVISLAB
Market Information
Market Cap i₹1.53B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,566253,443
90 Day Avg. Volume i2,815283,911
Last Close₹500.65₹6,608.50
52 Week Range₹360.00 - ₹624.95₹5,636.50 - ₹7,071.50
% from 52W High-19.89%-6.55%
All-Time High₹1,190.00 (Jul 24, 2017)₹7,071.50 (Jul 08, 2025)
% from All-Time High-57.93%-6.55%
Growth Metrics
Quarterly Revenue Growth-0.06%0.12%
Quarterly Earnings Growth-0.55%-0.01%
Financial Health
Profit Margin (TTM) i0.16%0.24%
Operating Margin (TTM) i0.06%0.30%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i0.410.58
Cash & Liquidity
Book Value per Share (MRQ)₹596.42₹580.95
Cash per Share (MRQ)₹286.45₹122.95
Operating Cash Flow (TTM) i₹106.44M₹19.67B
Levered Free Cash Flow (TTM) i₹241.56M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.29%0.91%
Last 12-Month Dividend i₹1.50₹60.00

Valuation & Enterprise Metrics Analysis: Coral Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricCORALAB (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i11.0667.11
Forward P/E i7.4553.75
PEG Ratio i-0.204.63
Price to Sales (TTM) i1.7716.18
Price to Book (MRQ) i0.7310.82
Market Capitalization
Market Capitalization i₹1.53B₹1.69T
Enterprise Value i₹532.28M₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i0.6115.86
Enterprise to EBITDA i4.4448.63
Risk & Other Metrics
Beta i0.900.19
Book Value per Share (MRQ) i₹596.42₹580.95

Financial Statements Comparison: Coral Laboratories Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORALAB (2025)DIVISLAB (2025)
Revenue/Sales i1.13B93.25B
Cost of Goods Sold i561.92M38.70B
COGS % of Revenue i49.6%41.5%
Gross Profit i569.87M54.55B
Gross Margin i50.4%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i246.11M25.71B
Operating Margin i21.7%27.6%
EBITDA i353.48M33.19B
EBITDA Margin i31.2%35.6%
Pre-Tax Income i324.70M29.16B
Pre-Tax Income % of Revenue i28.7%31.3%
Income Tax i83.15M7.25B
Income Tax % of Revenue i7.3%7.8%
Net Income (Profit) i241.56M21.91B
Profit Margin i21.3%23.5%

Balance Sheet & Liquidity Metrics

MetricCORALAB (2025)DIVISLAB (2025)
Cash & Equivalents i34.06M4.15B
Total Current Assets i1.77B100.81B
Total Current Assets % of Revenue i156.0%108.1%
Total Current Liabilities i249.58M14.52B
Total Current Liabilities % of Revenue i22.1%15.6%
Long-Term Debt i020.00M
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i2.01B149.69B
Retained Earnings i1.71B134.00B
Retained Earnings % of Revenue i151.0%143.7%
Property, Plant & Equipment i217.44M3.19B

Cash Flow Statement Comparison

MetricCORALAB (2025)DIVISLAB (2025)
Operating Cash Flow i106.44M19.67B
Operating Cash Flow % of Revenue i9.4%21.1%
Capital Expenditures i-29.45M-14.38B
Free Cash Flow i-41.67M2.15B
FCF Margin i-3.7%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.57M265.47M
Float Shares i802,609117.72M
% Held by Insiders i78.86%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i21.14%19.31%

Dividend Analysis & Yield Comparison: Coral Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricCORALABDIVISLAB
Last 12-Month Dividend i₹1.50₹60.00
Last 12-Month Dividend Yield i0.29%0.91%
3-Year Avg Annual Dividend i₹1.17₹50.00
3-Year Avg Dividend Yield i0.26%0.70%
3-Year Total Dividends i₹3.50₹150.00
Ex-Dividend DateSep 19, 2025Jul 25, 2025